Amedisys, Inc. (NASDAQ:AMED) Stock Position Raised by Twin Securities Inc.

Twin Securities Inc. lifted its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 143.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 29,105 shares of the health services provider's stock after purchasing an additional 17,160 shares during the quarter. Amedisys comprises 1.5% of Twin Securities Inc.'s portfolio, making the stock its 11th largest position. Twin Securities Inc. owned approximately 0.09% of Amedisys worth $2,642,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Trexquant Investment LP increased its position in Amedisys by 1,317.8% in the 4th quarter. Trexquant Investment LP now owns 87,719 shares of the health services provider's stock valued at $7,964,000 after acquiring an additional 81,532 shares during the period. ABC Arbitrage SA acquired a new stake in Amedisys in the 4th quarter valued at approximately $2,522,000. Schonfeld Strategic Advisors LLC increased its position in Amedisys by 17.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 4,500 shares of the health services provider's stock valued at $409,000 after acquiring an additional 671 shares during the period. Empowered Funds LLC acquired a new stake in Amedisys in the 4th quarter valued at approximately $318,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in Amedisys in the 4th quarter valued at approximately $590,000. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AMED has been the topic of several analyst reports. Stephens restated an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a research report on Tuesday, March 4th. Royal Bank of Canada restated an "outperform" rating and issued a $100.00 target price on shares of Amedisys in a research report on Wednesday, April 16th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat, Amedisys currently has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Price Performance

Shares of AMED stock traded down $1.15 during mid-day trading on Wednesday, hitting $93.59. 423,980 shares of the stock traded hands, compared to its average volume of 419,522. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95. The firm has a market cap of $3.07 billion, a price-to-earnings ratio of 37.14, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96. The company's 50-day simple moving average is $93.30 and its 200-day simple moving average is $91.62. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same period last year, the firm earned $1.03 EPS. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. As a group, equities research analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.